Adhesion of platelets to the subendothelium of blood vessels at sites of vascular injury under high shear conditions is mediated by a direct interaction between the platelet receptor glycoprotein Ibα (GpIbα) and the A1 domain of von Willebrand factor (VWF). Here we report the 2.6 Å crystal structure of a complex comprised of the extracellular domain of GpIbα and the wild type A1 domain of VWF. Direct comparison of this structure to a GpIbα-A1 complex containing "gain-of-function" mutations, A1-R543Q and GpIbα-M239V, reveals specific structural differences between these complexes at sites near the two GpIbα-A1 binding interfaces. At the smaller interface, differences in interaction show that the α1-β2 loop of A1 serves as a conformational switch, alternating between an open α1-β2
INTRODUCTION

Adhesion of blood platelets to sites of vascular injury is mediated by von Willebrand factor (VWF)
1 , a large, multimeric plasma glycoprotein that binds to both exposed connective tissue and platelet surface receptors (1,2). VWF is localized to the site of injury via attachment of its A3 domain to exposed collagen in the subendothelium (3).
Subsequently, platelets are recruited through a direct interaction between the multimeric glycoprotein receptor complex GpIb-IX-V on the platelet surface, and the A1 domain of immobilized VWF (4) . GpIb-IX-V is comprised of four transmembrane subunits: GpIbα, GpIbβ, GpIX, and GpV, and the binding site for A1 is localized to the extracellular domain of GpIbα (5) . There is no measurable binding of normal VWF to platelets in circulating blood, and binding of VWF to GpIbα requires high shear conditions generated by rapidly flowing blood (6) . At lower flow rates, platelet adhesion is independent of GpIbα and VWF and involves other adhesive interactions, including those between collagen and GpIa-IIa (integrin α 2 β 1 ) (7, 8) and those between fibrinogen and GpIIb-IIIa (integrin α IIb β 3 ) (6) . In addition to its role in platelet adhesion, data from confocal videomicroscopic studies suggest that GpIbα-VWF association contributes to platelet aggregation and thrombus growth (9, 10) .
Von Willebrand disease (VWD) is the one of the most common congenital bleeding disorders, with a prevalence of at least 100 per million individuals (11, 12) . Type 2B VWD is caused by a qualitative abnormality of VWF in which normal sized multimers of VWF are secreted, and platelet-VWF interaction is augmented by increased affinity of VWF for
GpIbα that does not require any mediating substance (13, 14) . Paradoxically, this gain-offunction is associated with bleeding, perhaps because the largest multimers spontaneously associate with platelets, leaving the circulation deficient in large, potent forms of VWF (13, 15, 16) . At least 14 distinct mutations are associated with type 2B VWD (1, 17, 18) , and most of these mutations cluster in a single disulfide loop of the VWF A1 domain between residues Cys4 presence of biological agents like ristocetin (22) . Biochemical studies show that this disulfide loop encompasses the binding sites for GpIbα, heparin, and sulfatides (23) (24) (25) .
Platelet-type or "pseudo" VWD is associated with mutations in GpIbα that enhance affinity for VWF in the absence of injury and elevated shear stress, including Met 239 to Val substitution (26) (27) (28) . Patients with either type 2B or platelet-type VWD show similar abnormalities, including loss of high molecular weight multimers of VWF in plasma, increased ristocetin-induced platelet aggregation, prolonged bleeding time, and intermittent thrombocytopenia (13, 27, 29, 30) , and recent binding studies suggest that both disorders have similar alterations in GpIbα-VWF bond formation and dissociation (31, 32) .
Crystal structures of the unliganded VWF A1 domain (A1), the unliganded extracellular domain of GpIbα, and a complex comprised of gain-of-function mutants of GpIbα and A1 have been determined (33) (34) (35) . The overall fold of GpIbα consists of a central domain of 8 leucine-rich repeats (LRRs), that is flanked by a β-hairpin at the Nterminal end (residues Cys 4 -Cys 17 ), and a conserved disulfide loop and the anionic region at the C-terminal end (34, 35) . Structural, biochemical, and mutagenesis data identify two sites on the concave face of GpIbα that interact with A1: the N-terminal β-hairpin and a flexible loop at the C-terminal end termed the regulatory "β-switch" region, which undergoes conformational rearrangement upon binding of VWF (35) (36) (37) . Based on the 3.1 Å co-crystal structure and binding data, it has been proposed that type 2B VWD mutations increase affinity of GpIbα-A1 interaction by displacing the N-and C-termini of A1 that could otherwise block GpIbα binding (35) . An alternate mechanism, based on the structure of A1 mutant I546V, has been proposed, suggesting that this mutation causes positional changes in the β2-β3 hairpin of A1 (27 Å away) which result in higher affinity for GpIbα (38) . In addition, binding studies of VWD mutants have indicated that both type 2B and platelet-type VWD mutations enhance platelet adhesion, in part, by reducing the GpIbα-A1 dissociation rate (31, 32) .
To gain insight into the structural basis for the enhancement of adhesion observed with VWD mutations and to identify specific changes associated with these mutations, we 5 have crystallized a complex comprised of the extracellular domain of GpIbα and the wildtype A1 domain of VWF and determined the structure at 2.6 Å resolution. Comparison of this GpIbα-A1 structure with unliganded GpIbα, the A1 domain, and the co-structure of the complex containing gain-of-function proteins GpIbα-M239V and A1-R543Q reveals conformational rearrangement within regions of GpIbα and A1 that form the binding surfaces of these proteins. The structural changes accompanying both mutations provide a rationale for the observed enhanced binding in VWD.
EXPERIMENTAL PROCEDURES
Expression and Purification. Constructs encoding residues 1-305 of the mutated GpIbα domain lacking sites of glycosylation (N21D and N159D) were fused to the CH2- GpIbα domains (residues 1-288, note secondary cleavage site) were produced by digestion of the dimeric GpIbα-Fc with EK (39) . The liberated, heterogenous GpIbα proteins were further purified by gel filtration chromatography on a HiTrap Q Sepharose HP column (Pharmacia). Amino acid composition analyses and MALDI-TOF and ESI MS (in the negative ion modes) after proteolytic digestion were used to determine the GpIbα primary structure. Two peaks from the Q column corresponded to the predicted sizes of GpIbα with either two or three sulfated residues, and only the latter was used for crystal screening.
The wild type A1 domain (residues 496 to 709; numbering derived from the mature VWF subunit) was expressed as insoluble protein (inclusion bodies) in E. coli cells grown at 37°C. To express the selenomethionine-substituted form of A1, cells were grown in defined
LeMaster media supplemented with 75 µg/ml selenomethionine, induced at an OD 600 of 0.47 by addition of 500 µM IPTG and harvested after 4 hours at 37°C. Cells were lysed at 4°C in 50 mM Tris-HCl(pH 8.0), 10 mM NaCl, 10 % Glycerol, 1 mM EDTA, 1mM PMSF, 1 mM Oxidized glutathione was added to a concentration of 0.1 mM and the mixture was incubated for 16 hours at room temperature. Refolded A1 was dialyzed against 20 mM HEPES, 100 mM NaCl (pH 8.0) before application to a Toyopearl DEAE 550C column.
The unbound fraction from the DEAE column was applied to a Toyopearl CM 550S column.
Refolded A1 was recovered using a linear gradient from 20 mM HEP ES, 100 mM NaCl (pH based on the Bijvoet differences from a three wavelength MAD data set. The "heavy atom" model was then refined against a maximum likelihood target function using SHARP (42) .
Initial phases were improved by solvent flattening using Solomon as implemented in CCP4
(41).
Experimental maps with continuous density were obtained, and an initial model was constructed using QUANTA (Molecular Simulations, Inc.) and refined against data from 30 to 2.6 Å with CNS (43) . The final refined model, which includes polypeptide chains of GpIbα (residues 1-265) and of the VWF A1 domain (residues 506-702), as well as 296
water molecules, has a working R-value of 0.190 and a free R-value of 0.239 (Table 1 ). The stereochemistry is excellent, and there are no backbone torsion angles outside of the allowed regions of the Ramachandran plot. Structural figures were generated using Ribbons (44) and PyMOL (45) .
RESULTS AND DISCUSSION
Overall Structure of GpIbα-A1 and Comparison to Unliganded GpIbα and A1 -The
x-ray crystal structure presented herein (Fig. 1A) shows that the interaction between the wild type A1 and GpIbα involves the same binding interfaces as in the GpIbα-A1 complex comprised of mutant proteins, described previously (35) . As in the mutant structure, changes in conformation between unliganded GpIbα (34, 35) and GpIbα bound to A1 map to and C-terminal (Glu 700 -Pro 703 ) regions with well-defined electron density is quite different in our structure compared to unliganded A1. Differences in these regions and structural disorder in the A1 termini extensions have also been noted previously in comparison of unliganded A1 and the mutant GpIbα-A1 complex (35) .
The substantial rearrangement of the α1-β2 loop in the complex containing wild-type A1 represents a novel observation, which was not apparent in the mutant GpIbα-A1
complex, as will be described in greater detail below. In wild-type A1, the α1-β2 loop is shifted by more than 6 Å and rotated away from GpIbα upon complex formation (Fig. 1B) , whereas the α1-β2 loop of unliganded A1 adopts a position that would create a steric clash with GpIbα and therefore would be incompatible with receptor binding (Fig. 1C) .
Comparison of Wild-type and Mutant GpIbα-A1 Co-structures -The overall
GpIbα-A1 complex structure is in general similar to that of the GpIbα-M239V-A1-R543Q
complex with a root mean square deviation of 1.1Å after superposition of 459 matched Cα 9 atoms (Fig. 2) . However, thorough comparison of these co-structures reveals notable changes that have implications with regard to the different binding affinities of these proteins (14, 32, 35) .
Structural Differences in the α1-β2 loop of A1 -The most prominent differences between wild-type and mutant A1 domains are observed more than 15 Å away from the R543Q mutation site, and include reconfiguration of the α1-β2 loop, and changes involving residues that are in direct contact with GpIbα (Arg 571 , Glu 613 ).
The single amino acid Arg à Gln substitution affects the position of equivalent atoms without extensive disruption of structure in nearby regions. In both structures, with either Arg or Gln present at position 543, main chains of these residues adopt similar conformations participating in intrahelical hydrogen bonding at the C-terminal end of the α1-helix. Structural deviations associated with main chain rearrangement begin at Leu 544 ,
where the orientation of its carbonyl oxygen is flipped relative to its orientation in the mutant complex, thus extending the hydrogen-bond capping at the C-terminal end of the α1-helix (Fig. 3) In contrast, in the complex containing the R543Q substitution, the entire α1-β2 loop moves upward closer to the β3-α2 loop of A1 and toward GpIbα, adopting a more extended conformation and occluding the interior of the binding site (Fig. 4B) . As a result of this movement, contacts with the N-terminal region, described above, cannot be established in mutant A1, and instead the backbone of the α1-β2 loop is held in position by three internal hydrogen bonds found within the loop itself, but not observed in our structure (Fig. 3A, 3C ).
Importantly, the consequences of Arg à Gln substitution, as described above, become apparent only upon GpIbα binding, as unliganded wild-type A1 and its mutant GpIbα-bound counterpart retain comparable conformations, including Leu 544 , the entire α1-β2 region and contacts therein (Fig. 3) . This could be a reason why structural flexibility of the α1-β2 loop cannot be appreciated in the mutant complex alone. In fact, the conformation of the α1-β2 loop in all unliganded A1 structures (33, 38, 49) As a result of the structural variations described above, electrostatic interactions between A1 and residues at the N-terminal end of GpIbα (Fig. 4) are considerably different from those reported in the mutant structure (35) . Specifically, in our structure the side chain of Arg 571 from the β3-α2 loop flips to avoid close contacts introduced by GpIbα, suc h that its guanidinium group is stacked on the His 37 ring and makes direct hydrogen bonds with Asp 18 and Ser 39 (Fig. 4A ). In the mutant complex, Arg 571 is still in direct contact with GpIbα-M239V, but its side chain adopts an extended conformation and therefore becomes hydrogen bonded to alternative residues of GpIbα, Glu 14 and His 37 (Fig. 4B) . Moreover, in our structure Gln 548 , on the solvent-exposed surface of the α1-β2 loop itself, makes contacts 11 with the N-terminal region of A1, as previously mentioned, and is more than 10 Å away from Arg 571 , whereas in the mutant complex the Gln 548 side chain extends in the opposite direction to form a hydrogen bond with Arg 571 (35 chains of these residues swing away from the contact site into solvent (Fig. 4A) . Thus, compared to the A1-R543Q mutant complex, a net loss of two direct intermolecular hydrogen bonds is observed on wild type A1-GpIbα complex formation.
The A1-R543Q mutation results in a ~2.5-fold increase in affinity of the isolated A1 domain for GpIbα (35) . Several other mutations associated with congenital VWD also cluster in the α1-β2 loop, including insertion of a Met at 540, and substitutions at residues domain in vitro show that enhanced affinity is a consequence of a ~6-fold reduction in the GpIbα-A1 dissociation rate in A1 domains bearing type 2B mutations (R543Q, R543W, and I546V) (31) . Consistent with this, A1-R543Q maintains a conformation that reinforces electrostatic interaction with GpIbα, while wild type A1 appears to be engaged in relatively fewer electrostatic contacts with the receptor. These structural differences result from appreciable conformational alteration of the α1-β2 loop that provides an appropriate electrostatic environment for this interaction site. Therefore, the α1-β2 loop may play an important role in regulating binding affinity of A1, by switching between an extended conformational isomer that would favor tight association under high-shear, as seen in the mutant comp lex, and an open isomer that would allow faster dissociation of GpIbα-A1 under normal conditions, as observed in the wild-type complex.
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Structural changes have been also reported in the unliganded I546V mutant of A1 (38) . It has been suggested that the I546V mutation enhances GpIbα binding and thus enhance initiation and stability of platelet adhesion, in part, as a consequence of rearrangement of the β2-β3 loop (27 Å away), and stabilization of this loop by a His 559 -Gly 561 hydrogen bond. The significance of this finding is not easy to reconcile with the GpIbα-A1 complex structures discussed herein, given that in the wild type complex the His 559 -Gly 561 interaction is also observed, which is even stronger (3.1 Å) than in the R543Q mutant complex (3.6 Å) (Fig. 6)(35) . Given that the I546V mutation is situated directly on the α1-β2 loop, the effect of this substitution might instead be mediated through isomeric conformations of the α1-β2 loop, somewhat similar to that seen in the A1-R543Q mutant complex.
The proximity of several type 2B mutations to A1 termini and the enhanced affinity associated with type 2B VWD, has led to the proposal that these mutations effect receptor binding by altering the conformation of the termini, which function as putative inhibitors of GpIbα binding (33, 35 ). An inhibitory role for the N-terminal extension is consistent with data showing that recombinant A1 domains lacking this extension bind to GpIbα with 5-to 10-fold greater affinity (50) , as well as with the apparent disorder of this extension in both wild type and mutant co-structures (35) . The displacement of the A1 termini from the interaction site would also be entirely compatible with reconfiguration of the α1-β2 loop, as partial unfolding or disorder of the terminal arms provides additional conformational freedom, augmenting the capacity for structural adaptation in this region.
Structural Variability in the β switch region of GpIbα -Modest but significant
changes in GpIbα between mutant receptor and receptor that lack the platelet-type VWD mutation are confined to two regions: the β-switch region, which interacts extensively with A1 and includes the mutation site, and a region within the cysteine loop, at a substantial distance from the GpIbα-A1 interaction site (residues Asp 249 -Phe 254 ). The cysteine loop of GpIbα in the wild-type GpIbα-A1 complex adopts a conformation which closely resembles that of unliganded GpIbα (data not shown) (34) . However, this loop adopts a different 13 conformation in the mutant GpIbα-A1 complex (35) , and interpretation of any possible biological significance of this altered conformation is tempered by observed crystal contacts involving several residues within this cysteine loop in the mutant co-structure.
Consequently, detailed comparison will focus on the significance of structural divergence near the mutation site in GpIbα and sites of interaction, as addressed below.
In the GpIbα-A1 complex structure, the regula tory β-switch region of GpIbα is positioned close to A1 to form a continuous β sheet between the two proteins ( Fig. 5 and (35) (Fig. 5) . In particular, while in the mutant structure, the indole ring of Trp 230 is buried deeply into the hydrophobic core of the interface, in the wild type structure it is forced into a new orientation, in which the hydrophobic portion of the ring becomes solvent accessible. In effect, the observed exposure of the indole ring, and hence a slight increase in the accessible volume of the interface, may result in the loss of entropy. As hydrogen bonding interactio ns observed at this interface are conserved in the two structures, the reduced entropy term due to the solvent reorganization may on the whole compensate for the enhanced van der Waals interactions with the methionine side chain.
The local structural cha nges described above propagate further, resulting in conformational divergence at the far end of the β-hairpin. In both structures, the two β-14 strands from the β hairpin are paired by the same network of main chain hydrogen bonds, with one exception noticeable at the tip of the loop. In the mutant structure, the loop end of the β-hairpin adopts a classic γ-turn configuration defined by a strong intraturn hydrogen bond (2.4 Å) formed between the carbonyl oxygen of Gly 233 and the amide of Asp 235 (Fig.   6B ). These tight γ-turns are frequently found to stabilize the end of β-hairpins to provide a change in the polypeptide chain direction (51, 52) . In contrast, in our co-structure, the β-hairpin loop adopts an "inverse γ-turn" configuration (Fig. 6A) , a γ-turn enantiomer with weaker hydrogen bonding interaction between the equivalent Gly 233 -Asp 235 atoms (2.9 Å).
Inverse γ-turns are weak, as defined by hydrogen bonding criteria (53) , and rarely occur within β-hairpins. Though sometimes found at key position in proteins, these weak γ-turns have been suggested to function as intermediate conformers that stabilize β-strands before formation of β-sheets (54,55).
Overall, differences in GpIbα-A1 interaction associated with the M239V mutation are minor and localized, and for the most part identify features that had been anticipated (35) . However, conformational differences at the distal end of the β-hairpin are rather unusual. The M239V mutation increases the affinity of A1 binding ~6-fold (56), mainly by increasing association rate with little or no change in dissociation rate. Based on the mutant complex structure alone, it has been proposed that this mutation increases the rate of GpIbα-A1 association by stabilizing or priming the GpIbα β-switch region for binding to A1 (35) . In support to this hypothesis stands out the observation that the gain-of-function mutant GpIbα-M239V adopts a more stable β-hairpin conformation, nucleated by a strong γ-turn, compared to the wild type GpIbα that displays the same β-hairpin structure but a weak γ-turn. If these small conformational differences have an effect on binding affinity of GpIbα, then it is reasonable to assume that the β-hairpin alternating between discrete conformational states via γ-turn isomers is an important structural factor in modulating binding affinity of GpIbα. Similar conformational fine-tuning may account for higher affinity observed in GpIbα receptors with other platelet-type VWD mutations, as most of them are found within the β-hairpin (G233V, V234G, K237V) (27, 35) .
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Additional Remarks -The GpIbα-A1 structure represents the central component of the GpIbα-VWF complex, but gives us an incomplete portrait of a much larger, more elaborate assembly that includes additional domains of multimeric VWF, additional subunits of the GpIb-IX-V receptor complex, and additional proteins. Binding studies show that
GpIbα has a significantly lower affinity for native, multimeric VWF (Kd > 1 µM) than for the A1 domain alone (Kd = 30 nM), which suggests that additional domains in VWF play an inhibitory role in binding (35) . Biochemical studies have shown that the length of the A1 fragment has a significant effect on binding affinity and functiona l activity (36, 50, 57, 58) .
Peptides that correspond to sequences Clearly, there are additional regions of both GpIbα and VWF not included in our structure that are required for optimal binding and activity, and neither the wild-type structure nor the mutant structure depict the complete set of potential binding interactions that could occur between these proteins. It is possible that intricate multimeric GpIbα-VWF assembly could form, analogous to the reported GpIbα-thrombin complexes (62, 63) , as GpIbα is green, with a semi-transparent molecular surface depicted. (B) The α1-β2 loop of region of A1-R543Q. A1 is white, with the α1 helix, α1-β2 loop and β2 strand highlighted in blue. GpIbα is green, with a semi-transparent molecular surface depicted. 
